共 26 条
- [1] Pfizer deal for selectin inhibitor highlights potential of glycomimetic drugs [J]. Nature Reviews Drug Discovery, 2011, 10 : 890 - 890
- [2] Pfizer backs protein degrader drugs with Arvinas deal [J]. Chemistry World, 2021, 18 (09): : 16 - 17
- [4] Sulfated hyaluronic acid, a potential selectin inhibitor, ameliorates experimentally induced crescentic glomerulonephritis [J]. NEPHRON EXPERIMENTAL NEPHROLOGY, 2005, 99 (01): : E26 - E32
- [5] Proton pump-inhibitor : No potential for savings by generic drugs [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2007, 45 (12): : 1352 - 1352